The global markets were up driven by vaccine hopes - Monday Review, November 23

The global markets were up driven by vaccine hopes - Monday Review, November 23

The global stocks were higher amid positive data from AstraZeneca

The US

AstraZeneca's effect seems to linger over the markets. Moreover, the President-elect Joe Biden is looking to nominate a former Federal Reserve Chair as Treasury Secretary boosted the momentum. USA30 rose 1.13%, while USA500 went up 0.61%. TECH100 added 0.22%.

Gold settled at $1,835 per ounce after, during intraday trading, it reached a low of $1,828.25 – a level unseen since July 17.

Crude Oil settled up 1.9% at $43.25 per barrel.

The Dollar Index closed the day at 92.264.

Asia and Australia

The stocks traded mixedly at the beginning of the week, some focusing on the pharma companies' progress towards a viable COVID-19 vaccine. Others focused on the rising number of infections.

HongKong45 went down 0.14% as it is battling a new wave of COVID-19 infections.

Down under, Australia200 gained 0.53% as the country eased some COVID-19 restrictions.

Europe

AstraZeneca seems to be on everyone's lips, as it made Europe50 gain 0.5% - the most significant increase the benchmark had since February. Germany30 went up 1%, while France40 ended 0.8% higher. UK100 inched up 0.3%.

Brent Oil rose 1.5% to $45.75 per barrel.

EUR/USD settled at 1.1874 after it added 0.2%.

Sources: reuters.com, investing.com

The information presented herein is prepared by CAPEX.com and does not intend to constitute Investment Advice. The information herein is provided as a general marketing communication for information purposes only and as such it has not been prepared in accordance with legal requirements designed to promote the independence of investment research, and it is not subject to any prohibition on dealing ahead of the dissemination of investment research.

Users/readers should not rely solely on the information presented herewith and should do their own research/analysis by also reading the actual underlying research. The content herewith is generic and does not take into consideration individual personal circumstances, investment experience or current financial situation.

Therefore, Key Way Investments Ltd shall not accept any responsibility for any losses of traders due to the use and the content of the information presented herein. Past performance is not a reliable indicator of future results.